CureVac NV (CVAC)
4.66
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
CureVac Total Liabilities (Quarterly) : 314.18M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 314.18M |
| June 30, 2025 | 120.33M |
| March 31, 2025 | 103.24M |
| December 31, 2024 | 109.99M |
| September 30, 2024 | 144.52M |
| June 30, 2024 | 193.24M |
| March 31, 2024 | 263.00M |
| December 31, 2023 | 299.70M |
| September 30, 2023 | 254.42M |
| June 30, 2023 | 273.22M |
| March 31, 2023 | 282.77M |
| December 31, 2022 | 349.22M |
| Date | Value |
|---|---|
| September 30, 2022 | 279.71M |
| June 30, 2022 | 316.37M |
| March 31, 2022 | 391.42M |
| December 31, 2021 | 534.22M |
| September 30, 2021 | 1.122B |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 978.85M |
| September 30, 2020 | 305.54M |
| June 30, 2020 | |
| March 31, 2020 | 218.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| PAION AG | -- |
| Anbio Biotechnology | -- |
| Epigenomics AG | -- |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alkermes Plc | 2.585B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.338B |
| Shareholders Equity (Quarterly) | 1.024B |